|   | 
Details
   web
Records
Author various
Title Hepatitis C und Drogengebrauch : Handbuch : Grundlagen, Therapie, Prävention, Betreuung und Recht Type Book Whole
Year 2006 Publication Abbreviated Journal
Volume Issue Pages 216
Keywords AOD use; infection; hepatitis C; health promotion; workplace context
Abstract
Address
Corporate Author Thesis
Publisher Aktionsbündnis Hepatitis und Drogengebrauch; Akzept; Deutsche Gesellschaft für Suchtmedizin (DGS); JES - Bundesweites Selbsthilfe-Netzwerk Junkies; Bundesverband der Eltern und Angehörigen für akzeptierende Drogenarbeit Place of Publication Berlin Editor Stöver, Heino
Language German Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Approved no
Call Number 50-00832 Serial 54479
Permanent link to this record
 

 
Author Kerr, Norman
Title Inebriety or narcomania : its etiology, pathology, treatment and jurisprudence Type Book Whole
Year 1894 Publication Abbreviated Journal
Volume Issue Pages 780
Keywords AOD dependence; chemical addiction; alcohol; treatment and maintenance; jurisdiction; United Kingdom
Abstract The second edition of this well known work appeared in 1889, and in the interval between the appearance of these editions public opinion has come to concede the strength of the position assumed by the author in the first edition, “that inebriety is a disease, as curable as most other diseases, calling for medical, mental and moral treatment.”
Address
Corporate Author Thesis
Publisher H. K. Lewis Place of Publication London Editor
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition 3rd
ISSN ISBN Medium
Area Expedition Conference
Notes Approved no
Call Number 50-00884 Serial 62577
Permanent link to this record
 

 
Author Anderson, Peter
Title Handbook for action to reduce alcohol-related harm Type Book Whole
Year 2009 Publication Abbreviated Journal
Volume Issue Pages viii, 70
Keywords prevention; alcohol abuse; harm reduction; public policy on health; program planning; recommendations or guidelines
Abstract This handbook is designed primarily for people working in health ministries or who are responsible at the regional or municipal level for developing strategies and actions plans to reduce alcohol-related harm. The handbook begins by setting out the infrastructure needed for an effective action plan on alcohol. It then describes 10 areas for effective action: alcohol pricing, availability, marketing, illegally and informally produced alcohol, drink–driving, drinking environments, health care interventions, public awareness-raising, community and workplace action, and monitoring and evaluation. For each area, the handbook outlines strategies, lists questions to consider, offers options for action, lists partners for action and provides a short bibliography of tools and supporting materials.
Address
Corporate Author Thesis
Publisher WHO Regional Office for Europe Place of Publication Copenhagen Editor Møller, Lars; Matic, Srdan
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Approved no
Call Number 50-10617 Serial 54489
Permanent link to this record
 

 
Author various
Title Drug policy guide Type Book Whole
Year 2010 Publication Abbreviated Journal
Volume Issue Pages v, 114
Keywords government and politics; program planning; laws and regulations; AOD public policy strategy; AOD use, abuse, and dependence; drug market; recommendations or guidelines; cooperation; international area
Abstract This is the first edition of the IDPC Drug Policy Guide aimed at national government policy makers. This publication is a collaborative effort by a number of IDPC members and partners, and brings together global evidence and best practices on the design and implementation of drug policies and programmes at national level. We are in an era of uncertainty for national policy makers in this field – drug problems and related challenges are increasing and it is increasingly clear that simple ‘war on drugs’ approaches are not succeeding in eradicating the problem. There are a growing number of policy and programme options available to address the harms that are associated with drug markets and drug use. Politicians and officials therefore face the challenge of defining a set of policies and programmes that are appropriate for the situation in their country. This guide, and the network of expertise that exists across the IDPC, is designed to help in that process. Each chapter describes the nature of the policy challenges and the range of evidence and experiences around the world, and sets out advice and recommendations for effective policy going forward.
Address
Corporate Author Thesis
Publisher International Drug Policy Consortium (IDPC) Place of Publication London Editor
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Aussi disponible en français: 50-11734 Approved no
Call Number 50-11074 Serial 54495
Permanent link to this record
 

 
Author various
Title Politique des drogues : un guide de l'IDPC Type Book Whole
Year 2010 Publication Abbreviated Journal
Volume Issue Pages v, 123
Keywords government and politics; program planning; laws and regulations; AOD public policy strategy; AOD use, abuse, and dependence; drug market; recommendations or guidelines; cooperation; international area
Abstract Les gouvernements sont confrontés à des défis de plus en plus complexes pour répondre aux problèmes liés aux marchés et à la consommation de drogues illégales sur leur territoire. Dans le monde entier, les responsables politiques commencent à se rendre compte que la « guerre contre la drogue » qui a été menée ces dernières années n’a pas réussi à éradiquer les cultures illégales ou à réduire l’ampleur des marchés de drogues et les niveaux de consommation. Les gouvernements doivent dorénavant développer une approche intégrée et équilibrée qui puisse, à la fois, endiguer les marchés de drogues illégales et minimiser les risques associés à la drogue. « Politiques des drogues: Un guide de l’IDPC » rassemble des preuves et exemples de bonne pratique sur les politiques relatives aux drogues illégales, et fournit des recommandations détaillées découlant de ces expériences, afin de guider les responsables politiques nationaux dans la révision de leurs politiques sur la drogue. Le guide est divisé en quatre sections: • Principes généraux • Justice pénale • Programmes sanitaires et sociaux • Renforcer les communautés Ce Guide a été publié en 2010, à la suite d’un travail de recherche et de consultation de notre réseau d’experts. Il sera actualisé régulièrement afin de refléter à tout moment les preuves et exemples de bonne pratique à travers le monde.
Address
Corporate Author Thesis
Publisher Consortium international sur les politiques des drogues (IDPC) Place of Publication Londres Editor
Language French Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Also available in English: 50-11074 Approved no
Call Number 50-11734 Serial 54497
Permanent link to this record
 

 
Author Schäffer, Dirk; Stöver, Heino; Höpfner, Christine
Title Drogen, HIV/AIDS, Hepatitis : Ein Handbuch Type Book Whole
Year 2011 Publication Abbreviated Journal
Volume Issue Pages 308
Keywords addiction; AOD consumption; drug; drug consumption; drug decriminalization; harm reduction; HIV infection; Aids; hepatitis; methadone; Germany
Abstract Die Fortschritte in der akzeptierenden Drogenarbeit sichtbar machen und dazu ermutigen, noch nicht Erreichtes engagiert anzugehen – dazu will dieses Handbuch beitragen. Vieles ist heute selbstverständlich, was vor Jahrzehnten noch auf vehementen Widerstand stieß. Der Ansatz „Harm-Reduction“ ist fest im Drogenhilfesystem verankert und inzwischen zu einer erfolgreichen gesundheitspolitischen Strategie avanciert: nicht nur auf Bundesebene, sondern – als Bestandteil des Europäischen Drogenaktionsplans – ebenso auf EU-Ebene und schließlich auch weltweit: Der im Juni 2011 erschienene „Report of the Global Commission on Drug Policy“ unter der Leitung des ehemaligen brasilianischen Präsidenten Fernando Henrique Cardoso etwa betont, dass die frühe Einführung von Harm-Reduction-Maßnahmen und geringe HIV-Prävalenzen unmittelbar zusammenhängen. Für Deutschland trifft dies ganz besonders zu, wie die Daten des Robert Koch-Instituts vom Mai 2011 zeigen: Die Anteile der HIV-Erstdiagnosen bei Menschen mit dem Infektionsrisiko „intravenöser Drogenkonsum“ sind zwischen 2001 und 2010 kontinuierlich von 8 % auf 3,2 % zurückgegangen. Das sind günstige Voraussetzungen, um bei den politisch Verantwortlichen dringend nötige Verbesserungen im Arbeitsfeld „Drogen, HIV/Aids und Hepatitis“ einzufordern und auch in der eigenen Arbeit Vorstöße zu wagen, die bei Drogen gebrauchenden Menschen zu einem Mehr an Gesundheit beitragen. Allerdings wird immer deutlicher, dass die prohibitiv orientierte, auf Repression setzende Drogenpolitik selbst für erhebliche gesundheitliche und soziale Probleme gesorgt hat, was auf der Welt-Aids-Konferenz 2010 in Wien endlich einmal deutlich ausgesprochen wurde. In der dort verabschiedeten Deklaration heißt es, dass Drogenpolitik evidenzbasiert sein muss, statt moralisch und ideologisch geprägt zu sein. Hier ist eine umfassende strategische Neuorientierung erforderlich.
Address
Corporate Author Thesis
Publisher Deutsche AIDS-Hilfe (DAH) Place of Publication Berlin Editor
Language German Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Approved no
Call Number 50-12126 Serial 54500
Permanent link to this record
 

 
Author Aitken, Campbell; Batey, Robert; Bowden, Scott; Boyce, Neil; Cabassi, Julia; Campora, Carlo; Carruthers, Susan; Chen, Robert; Coates, Liz; Conrad, Sue; Crofts, Nick; Delalande, Cheryl; Gorst, Judith; Harley, Hugh; Harvey, Paul; Higgs, Peter; Jones, Judith; Lee, Jia-Yee; Locarnini, Stephen; Loveday, Stuart; Lowe, David; Mackintosh, Andrew; McCaw, Rhonda; McCoy, Ron; McDonald, Margaret; Mitchell, Jo; Mudge, Leonie; Orcher, Helen; Richmond, Jacqui; Ridge, Allison; Sansom, Deb; Sasadeusz, Joe; Savage, Jan; Sievert, William; Speed, Tamara; Taylor, Helen; Wallace, Jack; Ward, Jeff; Woodruff, Justin; Woolcock, Geoffrey
Title National hepatitis C resource manual Type Book Whole
Year 2001 Publication Abbreviated Journal
Volume Issue Pages iv, 250
Keywords viral hepatitis; hepatitis C; HIV infection; diagnosis; harm reduction; peer; education; treatment and maintenance; government and politics; training manual; health care worker; Australia
Abstract This manual has been developed as as a concise source of standardised information about hepatitis C to assist health care workers. The aim of this resource is to enhance the health outcomes of people affected or potentially affected by hepatitis C, by providing standardised, accurate and current information about hepatitis C and associated issues to a wide range of health care providers.
Address
Corporate Author Thesis
Publisher Australian Government, Department of Health and Ageing Place of Publication Canberra Editor
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition 1st
ISSN ISBN Medium
Area Expedition Conference
Notes 2nd edition (2008) also available: 50-13208 Approved no
Call Number 50-13160 Serial 54506
Permanent link to this record
 

 
Author Batey, Robert; Dore, Greg
Title National hepatitis C resource manual Type Book Whole
Year 2008 Publication Abbreviated Journal
Volume Issue Pages iv, 250
Keywords prevention; viral hepatitis; hepatitis C; recommendations or guidelines; Australia
Abstract This manual has been developed as a concise source of standardised, currently available, information to assist health care workers.
Address
Corporate Author Thesis
Publisher Australian Government, Department of Health and Ageing Place of Publication Canberra Editor
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition 2nd
ISSN ISBN Medium
Area Expedition Conference
Notes 1st edition also available: 50-13160 Approved no
Call Number 50-13208 Serial 54508
Permanent link to this record
 

 
Author Dolan, Kate; Topp, Libby; MacDonald, Margaret
Title Needle and syringe programs : a review of the evidence Type Book Whole
Year 2000 Publication Abbreviated Journal
Volume Issue Pages 30
Keywords harm reduction; needle distribution and exchange; program evaluation; international area; Australia
Abstract This Review summarises the literature on the provision of sterile injecting equipment to people who inject drugs and other related issues. The proportion of the Australian population thought to inject drugs is about one percent or approximately 275,000 people. The first case of HIV infection in a drug injector without other risk factors in Australia was detected in 1985. In the following year, a Needle and Syringe Program started in Australia. At that time, hepatitis C infection was already well established among drug injectors with more than half being infected2. Staff at Needle and Syringe Programs provide much more than injecting equipment. They are often the first point of contact with health services for people who inject drugs, facilitating the entry of many drug users into drug treatment. Some Programs also provide primary medical care to this disadvantaged section of Australians whose health is usually very poor. Needle and Syringe Programs have reduced the transmission of HIV, hepatitis B and hepatitis C. The size of the reduction of HIV transmission due to Needle and Syringe Programs has been calculated to be at least 30 percent. Australia’s Needle and Syringe Programs were estimated to have prevented almost 3,000 cases of HIV infection in 1991 alone, a saving of $266 million. HIV epidemics have occurred recently in some cities in North America where Needle and Syringe Programs existed. Arbitrary restrictions on the number of needles and syringes provided from the Programs are thought to have been a critical weakness in their effectiveness in preventing transmission of blood borne viral infections. Research has shown that Needle and Syringe Programs do not increase injecting drug use or the number of discarded needles and syringes. Even though Needle and Syringe Programs enjoy a high level of support from the public in Australia and abroad, they also attract some criticism. Objections to Needle and Syringe Programs include: concern about specific locations, the inconsistency in providing some free injecting equipment to drug injectors but not to people with diabetes, concern that the Programs are responsible for all discarded injecting equipment in a local area and that the Programs condone drug use. Some members of the public are concerned that they may receive a needlestick injury from a discarded needle and syringe and then become infected with HIV or hepatitis. No cases of HIV, hepatitis B or hepatitis C infection resulting from a needlestick injury due to discarded injection equipment have been identified although researchers have investigated the outcomes of such injuries. There is abundant evidence from Australia and other countries of the public health benefits of Needle and Syringe Programs. The US Secretary for Health and Human Services, Donna Shalala, has announced that: “This nation is fighting two deadly epidemics – AIDS and drug abuse. They are robbing us of far too many of our citizens and weakening our future. A meticulous scientific review has now proven that needle exchange programs can reduce the transmission of HIV and save lives without losing ground in the battle against illegal drugs. It offers communities that decide to pursue needle exchange programs yet another weapon in the fight against AIDS (20 April 1998)” Countries that have implemented these Programs have averted HIV epidemics among injecting drug users, while countries that have not implemented these measures have often experienced uncontrolled epidemics. There is strong evidence that if HIV becomes endemic among injecting drug users, HIV can then spread to their sexual partners and children resulting in high mortality rates and large social and economic costs to the entire population.
Address
Corporate Author Thesis
Publisher Australian National Council on AIDS, Hepatitis C and Related Diseases (ANCAHRD) Place of Publication Sydney Editor
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Approved no
Call Number 50-13377 Serial 54510
Permanent link to this record
 

 
Author Dolan, Kate; Topp, Libby; MacDonald, Margaret; Silins, Edmund
Title Needle and syringe programs : a review of the evidence Type Book Whole
Year 2005 Publication Abbreviated Journal
Volume Issue Pages 31
Keywords harm reduction; needle distribution and exchange; program evaluation; international area; Australia
Abstract This booklet summarises the literature on the provision of sterile needles and syringes to people who inject drugs and other related issues. The proportion of the Australian population thought to inject drugs is just under two percent, or approximately 313,500 people.1 The first case of HIV infection in a drug injector without other risk factors in Australia was detected in 1985. Needle and Syringe Programs started in Australia the following year. At that time, hepatitis C infection was already well established among drug injectors with more than half being infected.2 Workers at Needle and Syringe Programs do much more than just provide injecting equipment. They are often the first point of contact between health services and people who inject drugs. Needle and Syringe Program workers are able to provide education and information on healthcare issues and drug related harm and facilitate entry into drug treatment. Some Programs also provide primary medical care to this disadvantaged population who often have very poor health. Australian Governments invested $130 million in Needle and Syringe Programs between 1991 and 2000. This resulted in the prevention of an estimated 25,000 cases of HIV and 21,000 cases of hepatitis C among injecting drug users. The savings to the health system in avoided treatment costs over a lifetime are estimated to be between $2.4 and $7.7 billion.3 While Needle and Syringe Programs enjoy strong public support in Australia, there have from time to time been misunderstandings about their role. In the past, Needle and Syringe Programs have been accused of encouraging drug use and increasing the number of inappropriately discarded needles and syringes in public places. However, Australian and international studies have shown that neither of these concerns are supported by impressive evidence. Research has shown that Needle and Syringe Programs do not increase injecting drug use. This could be attributed to the ability of health workers to offer health information, drug education and referral into treatment. Some members of the public have also raised concerns about inappropriately discarded needles and syringes and the possibility of contracting HIV or hepatitis C from a discarded used needle. The chance of a member of the public contracting either HIV or hepatitis C from a discarded used needle is extremely low. Worldwide, there has never been a reported case of a member of the public contracting HIV in this way. Countries where Needle and Syringe Programs have been implemented have averted HIV epidemics among injecting drug users, while countries that have not implemented these measures have often experienced uncontrolled epidemics. There is strong evidence that if HIV becomes endemic among injecting drug users it can then spread to their sexual partners and children resulting in high mortality rates and large social and economic costs to the entire community. There is abundant evidence from Australia and international research of the substantial public health benefits of Needle and Syringe Programs. The Australian Medical Association supports Needle and Syringe Programs as one of a number of measures which prevent the spread of HIV and other blood borne diseases.
Address
Corporate Author Thesis
Publisher Australian Government, Department of Health and Ageing Place of Publication Canberra Editor
Language English Summary Language Original Title
Series Editor Series Title (down) Abbreviated Series Title
Series Volume Series Issue Edition
ISSN ISBN Medium
Area Expedition Conference
Notes Approved no
Call Number 50-13378 Serial 54511
Permanent link to this record